Dederer L Iu, Gorbacheva L B
Antibiotiki. 1984 Jun;29(6):442-5.
Ruboxyl, a paramagnetic analog of rubomycin, was synthesized and subjected to a preliminary investigation at the Institute of Chemical Physics of the Academy of Sciences of the USSR. The drug is characterized by a higher antitumor activity, broader spectrum and lower general and cardiac toxicity. This is the first attempt of comparative biochemical investigation of rubomycin, ruboxyl and the nitroxyl radical at the level of DNA replication. The effect of these drugs on the synthesis of DNA in the cells of leukemia P-388, the bone marrow and heart of mice was studied. It was shown that the degree and duration of the DNA synthesis inhibition in the tumor cells correlated well with the antitumor activity of the drugs. On the 3rd day after administration rubomycin and ruboxyl induced stimulation of the DNA synthesis in the cells of the bone marrow. This might be explained by transfer of a part of the population of the bone marrow cells from Go phase due to the cytotoxic damages of the proliferating cells. The DNA synthesis stimulation in the bone marrow was most likely associated with the toxic effect of the drugs. No correlation between the cardiotoxicity and inhibition of the DNA synthesis in the heart cells of the mice was observed. The nitroxyl radical showed no biological activity on this model. The average lifespan of the mice treated with the nitroxyl radical was the same as that of the control animals. A decrease in the incorporation of 2-14C-thymidine into DNA of the tumor, bone marrow and heart was observed in the tumor carriers with development of the tumor.
柔红霉素的顺磁类似物鲁博昔尔(Ruboxyl)已合成,并在苏联科学院化学物理研究所进行了初步研究。该药物的特点是具有更高的抗肿瘤活性、更广泛的光谱以及更低的全身毒性和心脏毒性。这是在DNA复制水平上对柔红霉素、鲁博昔尔和硝酰自由基进行比较生化研究的首次尝试。研究了这些药物对白血病P - 388细胞、小鼠骨髓和心脏中DNA合成的影响。结果表明,肿瘤细胞中DNA合成抑制的程度和持续时间与药物的抗肿瘤活性密切相关。给药后第3天,柔红霉素和鲁博昔尔诱导了骨髓细胞中DNA合成的刺激。这可能是由于增殖细胞的细胞毒性损伤,使一部分骨髓细胞群体从G0期转移所致。骨髓中DNA合成的刺激很可能与药物的毒性作用有关。未观察到心脏毒性与小鼠心脏细胞中DNA合成抑制之间的相关性。在该模型中,硝酰自由基没有显示出生物活性。用硝酰自由基处理的小鼠的平均寿命与对照动物相同。在肿瘤发生的肿瘤携带者中,观察到2 - 14C - 胸苷掺入肿瘤、骨髓和心脏DNA的量减少。